Pharma Marketing News Vol. 10, No. 5: 10 MARCH 2011
Welcome to Volume 10, Issue #5 (10 MARCH 2011) of Pharma Marketing News.
Pharma Marketing News Vol. 10, No. 11: 21 June 2011
Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.
Proposed Rules for Physician Payment Sunshine Act
Looming Challenges Cloud Implementation. This article reviews the strategic implications of the Sunshine Act and also presents highlights of the draft regulations rule released by the Centers for Medicare and Medicaid Services on December 15, 2011.
Will Critics Kill Pharma’s Social Media Golden Egg Laying Goose?
The fear is that if the first steps by pharma to engage in social media conversation are too harshly scrutinized and criticized, the drug industry will shy away from getting more involved in social media.
The Socialisation of the Internet is Bogus
The whole web is now socialised..
Pharma Marketing News Vol. 10, No. 8: 28 April 2011
Welcome to Volume 10, Issue #8 (28 APRIL 2011) of Pharma Marketing News.
The Digital Health Coalition: Solving Real Problems — Mission Possible?
A conversation with Mark Bard, founder of the Digital Health Coalition, regarding the mission of the Coalition and what companies and individuals are involved.
The Phil Mickelson Enbrel Campaign
From the Audition in the Press to TV, Web, and Print Advertising. Pfizer and Amgen demonstrate how to launch a branded spokesperson campaign starting from a bit of over-the-top unregulated press relations to fully regulated TV, print, and Web advertising. It must be costing a mint!
Checking Under the Hood of Pharma Mobile Apps
Let's look 'under the hoods' of two pharma-sponsored mobile apps and compare disclaimers. We'll compare Janssen's PASI calculator, which has an update disclaimer, with the new AFib Educator 2.0 app developed by Sanofi-Aventis.
The Pharmaguy Social Media Timeline™: A Record of Social Media Events Impacting the Pharmaceutical...
The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline™ now, at a time when the industry already has set precedents in every social media application.
